A. Mueller

发表

The pharmacology of voltage-gated sodium channel activators

Irina Vetter, I. Vetter, J. Deuis, 2017, Neuropharmacology.

Multitarget nociceptor sensitization by a promiscuous peptide from the venom of the King Baboon spider

Stewart Heitmann, I. Vetter, David John Adams, 2022, Proceedings of the National Academy of Sciences.

Subcutaneous ω-Conotoxins Alleviate Mechanical Pain in Rodent Models of Acute Peripheral Neuropathy

I. Vetter, R. Lewis, A. Mueller, 2021, Marine drugs.

Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release

K. Schroder, I. Vetter, J. Lévesque, 2021, The Journal of experimental medicine.

Intra-colony venom diversity contributes to maintaining eusociality in a cooperatively breeding ant

I. Vetter, C. Schroeder, Vanessa Schendel, 2023, BMC Biology.

Inflammatory and neuropathic gene expression signatures of chemotherapy-induced neuropathy induced by vincristine, cisplatin and oxaliplatin in C57BL/6J mice.

I. Vetter, D. Carter, J. Deuis, 2019, The journal of pain : official journal of the American Pain Society.

Minocycline Prevents the Development of Mechanical Allodynia in Mouse Models of Vincristine-Induced Peripheral Neuropathy

M. Sweet, A. Mueller, R. Allavena, 2019, Front. Neurosci..

Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7

D. Craik, I. Vetter, C. Schroeder, 2020, The Journal of Biological Chemistry.

NaV1.7 as a pain target - From gene to pharmacology.

I. Vetter, M. Mobli, J. Deuis, 2017, Pharmacology & therapeutics.

A comprehensive portrait of the venom of the giant red bull ant, Myrmecia gulosa, reveals a hyperdiverse hymenopteran toxin gene family

I. Vetter, R. Payne, G. King, 2018, Science Advances.

A pain-causing and paralytic ant venom glycopeptide

I. Vetter, R. Payne, A. Keramidas, 2021, iScience.

Small cyclic sodium channel inhibitors.

D. Craik, I. Vetter, J. Tytgat, 2020, Biochemical pharmacology.

α-Conotoxin MrIC is a biased agonist at α7 nicotinic acetylcholine receptors.

I. Vetter, R. Lewis, N. Daly, 2015, Biochemical pharmacology.

A peptide toxin in ant venom mimics vertebrate EGF-like hormones to cause long-lasting hypersensitivity in mammals

I. Vetter, R. Norton, G. King, 2022, Proceedings of the National Academy of Sciences.

Recombinant production, bioconjugation and membrane binding studies ofPn3a, a selective NaV1.7 inhibitor.

I. Vetter, M. Mobli, J. Deuis, 2020, Biochemical pharmacology.

Anti-allodynic effects of the selective NaV1.7 inhibitor Pn3a in a mouse model of acute post-surgical pain: evidence for analgesic synergy with opioids and baclofen.

I. Vetter, O. Cheneval, C. Schroeder, 2019, Pain.

Mapping the Molecular Surface of the Analgesic NaV1.7-Selective Peptide Pn3a Reveals Residues Essential for Membrane and Channel Interactions.

I. Vetter, Q. Kaas, C. Schroeder, 2020, ACS pharmacology & translational science.